MED
MEDStock
OFF
Close before Sep 9 scan
$12.16
Indicators

Loading indicators…

Sentiment Sources
StockTwits
News (Finnhub)
Sources: StockTwits, Finnhub+VADER
Split Clock
CROWD
WIRE
STREET
TAPE
Smart Money

Medifast, Inc. (MED) Stock Analysis

A live, multi-source view of Medifast, Inc. (MED): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.

About Medifast, Inc.

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements.

Sector: Consumer Cyclical · Industry: Personal Services · United States · 380 employees · medifastinc.com

Key statistics · as of 2026-09-06

As of 2026-09-06, Medifast, Inc. (MED) had a market capitalization of $141.2M (forward -45.1) and a beta of 0.73; the shares traded in a 52-week range of $9.22 – $14.67 (-8.6% over the year).

Market cap
$141.2M
Enterprise value
$-11.6M
Forward P/E
-45.1
PEG ratio
0.97
Price / book
0.66
EPS (trailing)
$-2.33
EPS (forward)
$-0.28
Payout ratio
0.0%
Ex-dividend date
2023-09-18
52-week range
$9.22 – $14.67
52-week change
-8.6%
Beta
0.73
Average volume
207,412
Shares outstanding
11.2M
Short % of float
16.90%
Profit margin
-8.1%

Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.

Last universe scan · 2026-09-09

In RapidTradeView’s 2026-09-09 scan of the US universe, Medifast, Inc. (MED) last closed at $12.16 (the last completed close before that scan).

Technicals at the scan: RSI 55 (neutral territory), price +1.8% versus its 20-day average, 20-day versus 50-day average spread +6.7%, MACD histogram 0.01.

Sentiment inputs: 100% of recent Finnhub-scored headlines read bullish; StockTwits 100% bullish.

Next scheduled company event: in 61 days from the scan date.

Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.

Smart Money · last 90 days

Members of Congress disclosed 0 buys and 0 sells of MED; corporate insiders filed 8 buys and 0 sells (1 filer, latest disclosure 2026-08-28). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Parsa Kiai (8B/0S). Who is trading what

RapidTradeView pick record

MED has not appeared in the daily picks yet. Full scoreboard

What this page covers

RapidTradeView pulls Medifast, Inc. (MED) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:

  • Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
  • Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
  • Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
  • News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
  • Earnings — current EPS, year-over-year change and the next scheduled earnings date.
  • Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.

How to read the signals

No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell MED.

Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.